Mitsukuchi M, Nakagami J, Ikemoto T, Higuchi S, Tarumoto Y, Yasui H, Sota K
Chem Pharm Bull (Tokyo). 1989 Jun;37(6):1534-9. doi: 10.1248/cpb.37.1534.
A series of 17-succinyl derivatives of four corticosteroids was prepared. They were tested for vasoconstrictive activity in humans, using 9 alpha-fluoro-11 beta, 21-dihydroxy-16 beta-methyl-17 alpha-valeryloxy-1,4-pregnadiene-3,20-dione (betamethasone 17-valerate, BV) as a standard. The activities of the 21-chloro 17-methylsuccinate compounds (6A, 6C and 6D) were greater than that of BV. A structure-activity relationship study showed that the activities of the 21-chloro 17-methylsuccinates were more potent than those of the corresponding 21-esters.
制备了四种皮质类固醇的一系列17-琥珀酰衍生物。以9α-氟-11β,21-二羟基-16β-甲基-17α-戊酰氧基-1,4-孕二烯-3,20-二酮(倍他米松17-戊酸酯,BV)为标准,对它们在人体中的血管收缩活性进行了测试。21-氯-17-甲基琥珀酸酯化合物(6A、6C和6D)的活性高于BV。构效关系研究表明,21-氯-17-甲基琥珀酸酯的活性比相应的21-酯更强。